Propanc Biopharma (PPCB) Treasury Shares (2015 - 2025)
Propanc Biopharma (PPCB) posted quarterly Treasury Shares of $46477.0 for Q4 2025, little changed year-over-year from $46477.0 in Q4 2024, and little changed quarter-over-quarter from $46477.0 in Q3 2025.
Propanc Biopharma (PPCB) Treasury Shares (2015 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Treasury Shares for 9 consecutive years, with $46477.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares changed 0.0% year-over-year to $46477.0; the TTM figure through Dec 2025 stood at $46477.0 (changed 0.0% YoY), while the FY2025 annual figure was $46477.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $46477.0 in Q4 2025 per PPCB's latest filing, from $46477.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $100.0 in Q4 2025 and bottomed at $0.0 in Q2 2022.
- Historically, Treasury Shares has averaged $10.7 across 4 years, with a median of $1.0 in 2021.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2021 and fell as far as 0.0% in 2021.
- Propanc Biopharma's Treasury Shares stood at $46477.0 in 2021, then changed by 0.0% to $46477.0 in 2022, then changed by 0.0% to $46477.0 in 2023, then changed by 0.0% to $46477.0 in 2024, then changed by 0.0% to $46477.0 in 2025.
- Business Quant data shows PPCB's Treasury Shares at $46477.0 in Q4 2025, $46477.0 in Q3 2025, and $46477.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | 100.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.00 |
| Dec 31, 2025 | 100.00 |
| Dec 31, 2025 | 46,477.00 |
| Dec 31, 2025 | 46,477.00 |
| Sep 30, 2025 | 46,477.00 |
| Sep 30, 2025 | 46,477.00 |
| Jun 30, 2025 | 46,477.00 |
| Jun 30, 2025 | 46,477.00 |
| Mar 31, 2025 | 46,477.00 |
| Mar 31, 2025 | 46,477.00 |
| Dec 31, 2024 | 46,477.00 |
| Dec 31, 2024 | 46,477.00 |
| Sep 30, 2024 | 46,477.00 |
| Sep 30, 2024 | 46,477.00 |
| Jun 30, 2024 | 46,477.00 |
| Jun 30, 2024 | 46,477.00 |
| Mar 31, 2024 | 46,477.00 |
| Mar 31, 2024 | 46,477.00 |
| Dec 31, 2023 | 46,477.00 |
| Dec 31, 2023 | 46,477.00 |